(Q37808075)

English

The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

1 reference

based on heuristic

inferred from title

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

combined oral contraceptive pill

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Ilana J Halperin

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Shoba Sujana Kumar

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Donna F Stroup

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sheila E Laredo

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Human Reproduction

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

191-201

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

The effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

An observational study of Yasmin in the management of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Hypertriglyceridemia: its etiology, effects and treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEQ301

21 January 2018

Identifiers

10.1093/HUMREP/DEQ301

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37808075&oldid=1728820500"